Non-invasive in vivo analysis of early metastatic processes
早期转移过程的非侵入性体内分析
基本信息
- 批准号:09470506
- 负责人:
- 金额:$ 7.62万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
For elucidating early phase of tumor metastasis, we developed non-invasive method to determine metastatic tumor cell trafficking by PET. We have already observed the correlation between metastatic potential and metastatic cell accumulation in a target tissues. In the present study, we firstly clarified the involvement of selectins in the early tumor cell trafficking. We also observed sulfatide, a ligand for selectins, suppressed tumor metastasis. Secondly, we investigated the role of integrins in tumor metastatic process by using integrin transfectants. CHO cells were transfected with a chain of integrins, I.e., α2, α3, α4, α6, α9 and av. PET analysis indicated that integrin αvβ1 and α4β1 enhanced tumor cell accumulation in a target tissue. Furthermore, useful evidences were obtained about involvement of integrin avb3 in liver metastasis. Thirdly, we investigated the role of immune surveillance on the suppression of tumor metastasis. If small number of tumor cells were injected in experimental metastatic model, metastasis was not observed due to removal of tumor cells from target by immune defense system. In fact, metastasis was observed in mice which were pretreated for the depletion of macrophages even when small number of tumor cells were injected. And, in this case, removal of tumor cells from target tissues was suppressed by the determination of PET. Therefore, we clearly demonstrated that macrophage play an important role for suppressing metastasis in the early stage of metastatic processes.
为了阐明肿瘤转移的早期阶段,我们开发了通过PET确定转移性肿瘤细胞运输的非侵入性方法。我们已经观察到转移潜能与靶组织中转移细胞积累之间的相关性。在本研究中,我们首先阐明了选择素在早期肿瘤细胞运输中的作用。我们还观察到硫苷脂,选择素的配体,抑制肿瘤转移。其次,我们利用整合素基因转染系统研究了整合素在肿瘤转移过程中的作用。CHO细胞用整联蛋白链转染,即,α2、α3、α4、α6、α9和av。PET分析表明,整合素αvβ1和α4β1增强肿瘤细胞在靶组织中的积聚。整合素avb3参与肝转移的研究也获得了有用的证据。第三,我们研究了免疫监视在抑制肿瘤转移中的作用。如果在实验转移模型中注射少量的肿瘤细胞,则由于免疫防御系统将肿瘤细胞从靶点移除而未观察到转移。事实上,即使在注射少量肿瘤细胞时,也在预处理以消耗巨噬细胞的小鼠中观察到转移。并且,在这种情况下,通过PET的测定抑制了肿瘤细胞从靶组织中的去除。因此,我们清楚地证明了巨噬细胞在转移过程的早期阶段对抑制转移起重要作用。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tomohiro Asai, et al.: "5'-O-dipalmitoylphosphatidyl 2'-C-Cyano-2'-deoxy-1-β-D-arabiono-pentofuranosyl-cytosine Is Enhanced by Long-circulating Liposomalization"Biol. Pharm. Bull.. 21. 766-771 (1998)
Tomohiro Asai 等人:“5-O-二棕榈酰磷脂酰 2-C-氰基-2-脱氧-1-β-D-阿拉伯-呋喃戊糖基-胞嘧啶通过长循环脂质体化得到增强”Biol Bull。 ..21.766-771 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hironori Kikkawa, Daisei Miyamoto, Hidetoshi Imafuku, Chieko Koike, Yasuno Suzuki, Shoji Okada, Hideo Tsuka, Tatsuro Irimura and Naoto Oku: "Role of Sialylglycoconjugate(s) in the Initial Phase of Metastasis of Liver-metastatic RAW117 Lymphoma Cells."Jpn.
Hironori Kikkawa、Daisei Miyamoto、Hidetoshi Imafuku、Chieko Koike、Yasuno Suzuki、Shoji Okada、Hideo Tsuka、Tatsuro Irimura 和 Naoto Oku:“唾液酸糖复合物在肝转移性 RAW117 淋巴瘤细胞转移初始阶段的作用。”Jpn
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hironori Kikkawa,et al.: "Possible role immune surveillance at the initial phase of metastasis produced by B16BL6 melanoma cell"FEBS Lett.. 467. 211-216 (2000)
Hironori Kikkawa 等人:“免疫监视在 B16BL6 黑色素瘤细胞产生的转移初始阶段的可能作用”FEBS Lett.. 467. 211-216 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Dail Ishikawa, et al.: "GD1α-Replica peptides Functionally Mimic GD1 α, an Adhesion Molecule of Metastaric Tumor Cells, and Suppress the Tum or Metastasis"FEBS Lett.. 441. 20-24 (1998)
Dail Ishikawa 等人:“GD1α-复制肽功能性地模仿 GD1α(转移性肿瘤细胞的粘附分子)并抑制肿瘤或转移”FEBS Lett.. 441. 20-24 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masako Takikawa, et al.: "Suppression of GD1 α ganglioside-mediated tum or metastasis by liposomalized WHW-peptide"FEBS Lett.. 466. 381-384 (2000)
Masako Takikawa 等:“通过脂质体化 WHW-肽抑制 GD1 α 神经节苷脂介导的肿瘤或转移”FEBS Lett.. 466. 381-384 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKU Naoto其他文献
OKU Naoto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKU Naoto', 18)}}的其他基金
Development of FA-Snap, a smart DDS drug, for proposing an innovative therapeutic modality of ischemic stroke.
开发智能 DDS 药物 FA-Snap,提出缺血性中风的创新治疗方式。
- 批准号:
16H05081 - 财政年份:2016
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New development of diagnostic and therapeutic modality for ischemia/reperfusion injury by intelligent DDS
智能DDS缺血/再灌注损伤诊疗模式新进展
- 批准号:
23249005 - 财政年份:2011
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of novel nanoparticles for DDS, and establishment of Therapeutic modality for brain ischemia by use of these nanoparticles.
开发用于 DDS 的新型纳米粒子,并利用这些纳米粒子建立脑缺血的治疗方式。
- 批准号:
22659010 - 财政年份:2010
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
A novel targeting DDS for the treatment of autoimmune diseases and allergy
一种治疗自身免疫性疾病和过敏的新型靶向 DDS
- 批准号:
20390014 - 财政年份:2008
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Radical Treatment Modality for Curing Allergies and Immune Diseases by a Novel Consept, RTDDS
通过新概念 RTDDS 开发治疗过敏和免疫性疾病的根治方法
- 批准号:
18390052 - 财政年份:2006
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of Antineovascular Therapy by use of Structure-recognizing targeting probes
结构识别靶向探针抗血管治疗的建立
- 批准号:
15390050 - 财政年份:2003
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Angiogenesis Suppression and Cancer Treatment by Use of Neovascular Targeted Probe
利用新生血管靶向探针抑制血管生成和癌症治疗
- 批准号:
12470507 - 财政年份:2000
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cancer Photodynamic Therapy by use of RES-avoiding Liposomes
使用避免 RES 的脂质体进行癌症光动力治疗
- 批准号:
07672424 - 财政年份:1995
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DEVELOPMENT OF FUNCTIONAL RES-AVOIDING LIPOSOMES AND THEIR USE IN CANCER THERAPY
功能性再避免脂质体的开发及其在癌症治疗中的应用
- 批准号:
05671874 - 财政年份:1993
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Study of the Signal Transduction of and Cellular Response (Growth Stimulation and Cytotoxicity) to Tumor Necrosis Factor
肿瘤坏死因子的信号转导和细胞反应(生长刺激和细胞毒性)的研究
- 批准号:
02671023 - 财政年份:1990
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Novel optical detection methods for ultrafast positron emission tomography (PET)
用于超快正电子发射断层扫描 (PET) 的新型光学检测方法
- 批准号:
10664571 - 财政年份:2023
- 资助金额:
$ 7.62万 - 项目类别:
Synaptic density as a trait marker of early psychosis: a longitudinal [18F]SynVesT-1 positron emission tomography (PET) study
突触密度作为早期精神病的特征标记:纵向 [18F]SynVesT-1 正电子发射断层扫描 (PET) 研究
- 批准号:
479650 - 财政年份:2023
- 资助金额:
$ 7.62万 - 项目类别:
Operating Grants
Translation and validation of non-invasive measurement of PD-L1 levels with positron emission tomography (PET) in head and neck malignancies and intracranial metastases
头颈恶性肿瘤和颅内转移瘤中正电子发射断层扫描 (PET) 无创测量 PD-L1 水平的转化和验证
- 批准号:
10673593 - 财政年份:2022
- 资助金额:
$ 7.62万 - 项目类别:
Integrating quantitative positron emission tomography (PET) and magnetic resonance imaging (MRI) to measure neuroinflammation
集成定量正电子发射断层扫描 (PET) 和磁共振成像 (MRI) 来测量神经炎症
- 批准号:
RGPIN-2022-05052 - 财政年份:2022
- 资助金额:
$ 7.62万 - 项目类别:
Discovery Grants Program - Individual
Translation and validation of non-invasive measurement of PD-L1 levels with positron emission tomography (PET) in head and neck malignancies and intracranial metastases
头颈恶性肿瘤和颅内转移瘤中正电子发射断层扫描 (PET) 无创测量 PD-L1 水平的转化和验证
- 批准号:
10357112 - 财政年份:2022
- 资助金额:
$ 7.62万 - 项目类别:
High resolution positron emission tomography (PET) insert systems for multimodality PET/magnetic resonance imaging
用于多模态 PET/磁共振成像的高分辨率正电子发射断层扫描 (PET) 插入系统
- 批准号:
RGPIN-2017-04963 - 财政年份:2021
- 资助金额:
$ 7.62万 - 项目类别:
Discovery Grants Program - Individual
High resolution positron emission tomography (PET) insert systems for multimodality PET/magnetic resonance imaging
用于多模态 PET/磁共振成像的高分辨率正电子发射断层扫描 (PET) 插入系统
- 批准号:
RGPIN-2017-04963 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Discovery Grants Program - Individual
Inorganic approaches to 18F-based positron emission tomography (PET) imaging applications
基于 18F 的正电子发射断层扫描 (PET) 成像应用的无机方法
- 批准号:
2445849 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Studentship
Synergistic application of Positron Emission Tomography (PET) and high-resolution Magnetic Resonance Spectroscopic Imaging (MRSI) for accurate tumor delineation in radiation therapy treatment planning of glioblastomas
正电子发射断层扫描 (PET) 和高分辨率磁共振波谱成像 (MRSI) 的协同应用在胶质母细胞瘤放射治疗计划中准确描绘肿瘤
- 批准号:
436180 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Fellowship Programs
Synergistic application of Positron Emission Tomography (PET) and Magnetic Resonance Spectroscopic Imaging (MRSI) for accurate tumor delineation in radiation therapy treatment planning of glioblastomas
正电子发射断层扫描 (PET) 和磁共振波谱成像 (MRSI) 的协同应用在胶质母细胞瘤放射治疗计划中准确描绘肿瘤
- 批准号:
440379 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Fellowship Programs